Clinical trial
Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
NCT03438552 is registered in ClinicalTrials.gov with UNICANCER as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase I/II Multi-center Study Evaluating the Efficacy of Repeat Stereotactic Radiation in Patients With Intraprostatic Tumor Recurrence After External Radiation Therapy
- Lead sponsor
- UNICANCER
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- October 18, 2018
- Completion date
- November 30, 2030
- Enrollment
- 57 (actual)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
local recurrence of malignant tumor of prostate